Global Hepatitis E Diagnostics Market Overview
Introduction:
Hepatitis E diagnostics market accounted for US$ 5.0 billion in 2020 and is projected to register a moderate CAGR of 6.6 % over the forecast period.
Hepatitis E virus (HEV) is mainly responsible for the infection of acute viral hepatitis across the globe which directly affects on the liver. Hepatitis E virus directly transmitted by food and water contamination. Presence of viral RNA in the serum or faeces is the indication of presence of Hepatitis E Virus. For hepatitis E disease, there is no specific treatment has been developed yet. For Analysis of Hepatitis E virus, some biologic specimens such as stools and serum are used and which is performed on viral RNA. Liver biopsy is mainly used for the diagnosis of Hepatitis E Virus.
Major factors responsible for driving the growth of the hepatitis E diagnostic market are limited access to safe drinking water and poor sanitation which increases the incidence of liver Hepatitis E disease. In addition, rising scarcity of potable water, poor nutrition and government initiative regarding awareness are some among the major factors driving growth of the hepatitis E diagnosis market across the globe. However, high cost of diagnostics procedure and poor reimbursement policies are factors restraining growth of hepatitis E diagnostic market.
Global Hepatitis E Diagnostics Market Segmentation
Hepatitis E Diagnostics Market has been segmented on the basis of test type, end user and region.
On the basis of test type, hepatitis E diagnostic market has been segmented into ELISA HEV IgM Test kits, ELISA HEV IgG Test Kits, and RT-PCR Test Kits. The end user segment includes hospitals, diagnostic laboratories, research centers, and point of care.
On the basis of region, hepatitis E diagnostic market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The market in Asia Pacific accounted for major share in hepatitis E diagnostic market in terms of revenue, owing to increasing incidence of hepatitis E disease in some countries of this region. High incidence rate of hepatitis E among the population in the countries of Asia pacific such as Vietnam, Pakistan, Bangladesh, Burma, Kazakhstan, Thailand, and Bhutan.
Global Hepatitis E Diagnostics Market Key Players
Key players operating in the hepatitis E diagnostic market includes F. Hoffmann-La Roche Ltd., Beijing Wantai Biological Pharmacy Enterprise Co.Ltd., Fast-track diagnostics Ltd., Altana Diagnostics GmbH, Fortress Diagnostics Ltd., Mikrogen GmBH, Abbott Laboratories, Siemens Ag, MP Biomedicals LLC, and Primerdesign Ltd.
Global Hepatitis E Diagnostics Market Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Preview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Test Type
- Market Snippet, By End-User
- Market Snippet, By Region
- Opportunity Map Analysis
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Product Launch
- Impact Analysis
- PEST Analysis
- Porter’s Analysis
- Market Dynamics
- Market Segmentation, By Test Type, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- ELISA HEV IgM Test kits
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- ELISA HEV IgG Test Kits
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- RT-PCR Test Kits
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Overview
- Market Segmentation, By End-User, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Diagnostic Laboratories
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Research Centers
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Point of Care
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Overview
- Global Market, By Region, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Test Type, 2019 – 2029
- Market Size and Forecast (US$ Mn), By End-User, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Test Type, 2019 – 2029
- Market Size and Forecast (US$ Mn), By End-User, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Test Type, 2019 – 2029
- Market Size and Forecast (US$ Mn), By End-User, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Test Type, 2019 – 2029
- Market Size and Forecast (US$ Mn), By End-User, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Test Type, 2019 – 2029
- Market Size and Forecast (US$ Mn), By End-User, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Overview
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- F. Hoffmann-La Roche Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Fast-track diagnostics Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Altana Diagnostics GmbH
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Fortress Diagnostics Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Mikrogen GmBH
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Siemens Ag
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- MP Biomedicals LLC
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Primerdesign Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- F. Hoffmann-La Roche Ltd.
- Analyst Views
- Section
- Research Methodology
- About Us
- Contact
FAQs
Hepatitis E Diagnostics Market has been segmented on the basis of test type, end user and region.
The emerging trends in the global Hepatitis E diagnostics market include the development of rapid and accurate point-of-care tests for enhanced early detection and monitoring.
The Hepatitis E Diagnostics Market report typically considers regions such as North America, Europe, Asia-Pacific, Latin America, and the Middle East.
Key players operating in the global hepatitis E diagnostic market includes F. Hoffmann-La Roche Ltd., Beijing Wantai Biological Pharmacy Enterprise Co.Ltd., Fast-track diagnostics Ltd., Altana Diagnostics GmbH, Fortress Diagnostics Ltd., Mikrogen GmBH, Abbott Laboratories, Siemens Ag, MP Biomedicals LLC, and Primerdesign Ltd.
Hepatitis E diagnostics market accounted for US$ 5.0 billion in 2020 and is projected to register a moderate CAGR of 6.6 % over the forecast period.